This webcast series and supporting materials were developed by the Chronic Conditions faculty in conjunction with OmniaMed Communications. The sponsoring companies have had no input into the agenda, speaker selection, presentations or collateral content, with the exception of the symposium sessions, for which the respective sponsoring companies are fully responsible.
Adjuvanted Trivalent Influenza Vaccine ▼ Prescribing Information can be found here
Cell-based Trivalent Influenza Vaccine ▼ Prescribing Information can be found here.
Prescribing information and adverse event reporting details can also be found underneath the video player on this page.
Presenters: Beverley Bostock and Farzana Hussain
This promotional symposium was organised, funded and reviewed by CSL Seqirus for UK healthcare professionals only. CSL products were discussed in this promotional webinar.
GBR-FLU-25-0019 | June 2025
Adverse events should be reported. Reporting forms and information can be found at yellowcard.mhra.gov.uk. Adverse events relating to CSL Seqirus products should also be reported to Seqirus UK Limited on 01748 828816.
GBR-FLU-25-0019 | June 2025